Loading clinical trials...

Vibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR Stimulation | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Vibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR Stimulation

NCT06559098•Stanford University

View on ClinicalTrials.gov

Summary

The purpose of this study is to test the efficacy of vibrotactile coordinated reset(vCR) stimulation on human subject participants with advanced stage Parkinson's Disease who have previously received vCR therapy.

Eligibility

Age

18 - 100 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Any adult age 18 and older
•Idiopathic Parkinson's Symptoms between Hoehn and Yahr stages 2 to 4
•Fluent in English
•If patient is on medication that affects brain function or alters Electroencephalography (EEG) activity, the patient must feel comfortable going off this medication prior to EEG recording
•Appropriate social support if required during an off state.
•Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
•Feels comfortable going off Parkinson's Disease(PD) related medication during in person study visits
•Lives in the United States
•Having previously been enrolled in a vCR pilot study

Exclusion Criteria

•Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies
•Any current drug or alcohol abuse.
•Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
•Pregnancy, breast-feeding or wanting to become pregnant
•Physical limitations unrelated to PD that would affect motor ratings
•Craniotomy
•Brain surgery
•Patient is unable to communicate properly with staff (i.e., severe speech problems)
•Excessive drooling
•A type of hairstyle that would impede the use of an EEG cap
+3 more criteria

Key Dates

Start Date

January 1, 2025

Primary Completion Date

January 1, 2027

Completion Date

September 1, 2027

Last Updated

September 5, 2024

Enrollment

ESTIMATED participants

Conditions

Parkinson Disease

Interventions

Vibrotactile coordinated reset (vCR)

DEVICE

Contacts

Jessica K Yankulova

CONTACT

650-474-9547 jessky@stanford.edu

Ellyn Daly

CONTACT

ellynd@stanford.edu

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437

Autonomic FailurePure Autonomic Failure+3 more

View study

RECRUITINGNA

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

NCT06692920

Parkinson Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 5, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Vibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR Stimulation

Inclusion Criteria

Exclusion Criteria

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Montelukast in Parkinson Disease

Exercise for Cognitive Excellence in Parkinson's Disease

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients